Keywords
Last Name
Institution

THOMAS F. NEWTON

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
AddressONE BAYLOR PLAZA
HOUSTON TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pharmacology
    DivisionPharmacology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mahoney JJ, Haile CN, De La Garza R, Thakkar H, Newton TF. Electrocardiographic characteristics in individuals with cocaine use disorder. Am J Addict. 2017 Mar 01. PMID: 28248441.
      View in: PubMed
    2. Mahoney JJ, Kalechstein AD, De Marco AP, Newton TF, De La Garza R. The Relationship Between Premorbid IQ and Neurocognitive Functioning in Individuals With Cocaine Use Disorders. Neuropsychology. 2017 Jan 05. PMID: 28054825.
      View in: PubMed
    3. Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R. The ?-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 Sep; 26(9):428-35. PMID: 27379509; PMCID: PMC4970930 [Available on 09/01/17].
    4. De La Garza R, Yoon JH, Thompson-Lake DG, Haile CN, Eisenhofer JD, Newton TF, Mahoney JJ. Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder. Psychiatry Res. 2016 Nov 30; 245:133-140. PMID: 27541349.
      View in: PubMed
    5. Grasing K, Mathur D, DeSouza C, Newton TF, Moody DE, Sturgill M. Cocaine cardiovascular effects and pharmacokinetics after treatment with the acetylcholinesterase inhibitor donepezil. Am J Addict. 2016 Aug; 25(5):392-9. PMID: 27392137; PMCID: PMC4967259 [Available on 08/01/17].
    6. Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 Jul; 19(7). PMID: 27207905.
      View in: PubMed
    7. Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May; 77(5):e561-5. PMID: 27249080.
      View in: PubMed
    8. Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Kosten TR, Haque A, McDevitt JT. Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids. J Drug Abuse. 2015 Nov 23; 1(1):1-6. PMID: 26925466.
      View in: PubMed
    9. De La Garza R, Verrico CD, Newton TF, Mahoney JJ, Thompson-Lake DG. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2016 Mar; 19(3):pyv098. PMID: 26364275; PMCID: PMC4815469.
    10. Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9. PMID: 26239766.
      View in: PubMed
    11. Brewer AJ, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ, Kosten TR, Newton TF, De La Garza R. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304. PMID: 25850966; PMCID: PMC4414865.
    12. Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney Iii JJ, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, Kosten TR, Haque A, McDevitt JT. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug Alcohol Depend. 2015 Aug 1; 153:306-13. PMID: 26048639.
      View in: PubMed
    13. De La Garza R, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJ, Jayroe JB, Bandak SI, Reiman KZ, Neale AC, Pickford LB, Cunningham KA. Evaluation of the dopamine ?-hydroxylase (D?H) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3; 59:40-8. PMID: 25602710; PMCID: PMC4777897.
    14. Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6. PMID: 25424624.
      View in: PubMed
    15. Wesley MJ, Lohrenz T, Koffarnus MN, McClure SM, De La Garza R, Salas R, Thompson-Lake DG, Newton TF, Bickel WK, Montague PR. Choosing Money over Drugs: The Neural Underpinnings of Difficult Choice in Chronic Cocaine Users. J Addict. 2014; 2014:189853. PMID: 25197609; PMCID: PMC4150492.
    16. Verrico CD, Haile CN, Mahoney JJ, Thompson-Lake DG, Newton TF, De La Garza R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 Aug 1; 141:72-8. PMID: 24928479; PMCID: PMC4120836.
    17. Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71. PMID: 24951161; PMCID: PMC4119803.
    18. Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ, Reyes JA, Kosten TR, Newton TF, De La Garza R, Nielsen DA. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes Brain Behav. 2014 Jul; 13(6):559-64. PMID: 24528631; PMCID: PMC4079840.
    19. Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33. PMID: 24393456; PMCID: PMC4423531.
    20. De La Garza R, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ, Mojsiak J, Lao G, Anderson A, Kahn R. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3; 50:44-52. PMID: 24316175; PMCID: PMC4562471.
    21. Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ, De La Garza R, Charney DS, Newton TF, Mathew SJ. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014 Feb; 17(2):331-6. PMID: 24103211; PMCID: PMC3992942.
    22. Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013 Dec; 22(12):1549-68. PMID: 24033127; PMCID: PMC4422382.
    23. Haile CN, De La Garza R, Mahoney JJ, Newton TF. Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. Drug Alcohol Depend. 2013 Dec 1; 133(2):759-62. PMID: 23968815; PMCID: PMC4432865.
    24. Ross EL, Yoon JH, Mahoney JJ, Omar Y, Newton TF, De La Garza R. The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1; 46:113-9. PMID: 23796525; PMCID: PMC3955062.
    25. Grasing K, Mathur D, Newton TF, Desouza C. Individual predictors of the subjective effects of intravenous cocaine. Psychiatry Res. 2013 Aug 15; 208(3):245-51. PMID: 23768613; PMCID: PMC3747034.
    26. Brewer AJ, Mahoney JJ, Nerumalla CS, Newton TF, De La Garza R. The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users. Pharmacol Biochem Behav. 2013 May; 106:132-6. PMID: 23541494; PMCID: PMC3707485.
    27. Haile CN, Hao Y, O'Malley PW, Newton TF, Kosten TA. The ?1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats. Brain Sci. 2012; 2(4):619-33. PMID: 24961263; PMCID: PMC4061810.
    28. Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One. 2012; 7(11):e47702. PMID: 23144826; PMCID: PMC3493584.
    29. Kalechstein AD, Yoon JH, Mahoney JJ, Newton TF, Chang L, De La Garza R. d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers. Pharmacol Biochem Behav. 2012 Dec; 103(2):403-7. PMID: 22960612.
      View in: PubMed
    30. Mahoney JJ, Newton TF, Omar Y, Ross EL, De La Garza R. The relationship between lifetime stress and addiction severity in cocaine-dependent participants. Eur Neuropsychopharmacol. 2013 May; 23(5):351-7. PMID: 22748418.
      View in: PubMed
    31. Roll JM, Newton T, Chudzynski J, Cameron JM, McPherson S, Fong T, Torrington M. Preference for gamma-hydroxybutyrate (GHB) in current users. J Exp Anal Behav. 2012 May; 97(3):323-31. PMID: 22693361; PMCID: PMC3372955.
    32. Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ, Hawkins RY, Labounty KR, Ross EL, Aziziyeh AI, De La Garza R. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. Addict Behav. 2013 Feb; 38(2):1518-26. PMID: 22560371; PMCID: PMC3415581.
    33. Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic ?? receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854. PMID: 22319592; PMCID: PMC3272014.
    34. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Chang LC, Newton TF. Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2012 Oct; 15(9):1241-9. PMID: 22214752; PMCID: PMC3411896.
    35. Culbertson CS, Shulenberger S, De La Garza R, Newton TF, Brody AL. VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE. J Cyber Ther Rehabil. 2012; 5(1):57-64. PMID: 25342999.
      View in: PubMed
    36. De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27; 37(1):141-6. PMID: 22230648; PMCID: PMC3877939.
    37. Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug Alcohol Depend. 2011 Dec 1; 119(1-2):37-45. PMID: 21696894; PMCID: PMC3205249.
    38. Tziortzis D, Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2011 Apr; 98(2):196-202. PMID: 21215769.
      View in: PubMed
    39. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Newton TF. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):459-65. PMID: 21122811; PMCID: PMC3341926.
    40. Haile CN, De La Garza R, Newton TF. Methamphetamine Cured my Cocaine Addiction. J Addict Res Ther. 2010 Oct 14; 1(103). PMID: 23066512.
      View in: PubMed
    41. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody AL, Newton TF. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. PMID: 20643158; PMCID: PMC2951480.
    42. Kalechstein AD, De La Garza R, Newton TF. Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict. 2010 Jul-Aug; 19(4):340-4. PMID: 20653641; PMCID: PMC3341927.
    43. Newton TF, De La Garza R, Grasing K. The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. Psychiatry Res. 2010 Aug 30; 179(1):96-100. PMID: 20493549; PMCID: PMC2919653.
    44. Grasing K, Mathur D, Newton TF, DeSouza C. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend. 2010 Feb 1; 107(1):69-75. PMID: 19836169.
      View in: PubMed
    45. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol. 2010; 2:13-8. PMID: 27186086; PMCID: PMC4863281.
    46. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence. J Exp Pharmacol. 2009 Dec 01; 2010(2):13-18. PMID: 20689642.
      View in: PubMed
    47. De La Garza R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict. 2009 Nov-Dec; 18(6):481-7. PMID: 19874169; PMCID: PMC3341928.
    48. De La Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):173-80. PMID: 19781865; PMCID: PMC2815156.
    49. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):186-93. PMID: 19698734; PMCID: PMC2775447.
    50. Newton TF, De La Garza R, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict. 2009 Jul-Aug; 18(4):294-300. PMID: 19444733; PMCID: PMC3341929.
    51. Lin SN, Lamm L, Newton TF, Reid MS, Moody DE, Foltz R. A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma. J Anal Toxicol. 2009 Jun; 33(5):237-42. PMID: 19671242.
      View in: PubMed
    52. Culbertson C, De La Garza R, Costello M, Newton TF. Unrestricted access to methamphetamine or cocaine in the past is associated with increased current use. Int J Neuropsychopharmacol. 2009 Jun; 12(5):677-85. PMID: 19220922; PMCID: PMC2735335.
    53. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. PMID: 19776303; PMCID: PMC3350803.
    54. Mendelson J, Rawson R, Newton T, Galloway G, de Wit H, Dewey SL, Hart CL, Epstein DH. Treatment of methamphetamine dependence. Mayo Clin Proc. 2008 Mar; 83(3):369-70; author reply 370-1. PMID: 18316008.
      View in: PubMed
    55. De La Garza R, Shoptaw S, Newton TF. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol. 2008 Sep; 11(6):729-41. PMID: 18248689; PMCID: PMC2581751.
    56. De La Garza R, Mahoney JJ, Culbertson C, Shoptaw S, Newton TF. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav. 2008 Apr; 89(2):200-8. PMID: 18207225; PMCID: PMC4170947.
    57. Rotheram-Fuller E, De La Garza R, Mahoney JJ, Shoptaw S, Newton TF. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination. Psychiatry Res. 2007 Aug 30; 152(2-3):205-10. PMID: 17449110.
      View in: PubMed
    58. Reinhard MJ, Hinkin CH, Barclay TR, Levine AJ, Marion S, Castellon SA, Longshore D, Newton T, Durvasula RS, Lam MN, Myers H. Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav. 2007 Dec; 32(12):2727-36. PMID: 17499443; PMCID: PMC2679746.
    59. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13; 31(3):593-9. PMID: 17270333; PMCID: PMC1907363.
    60. Kalechstein AD, Fong T, Rosenthal RJ, Davis A, Vanyo H, Newton TF. Pathological gamblers demonstrate frontal lobe impairment consistent with that of methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2007; 19(3):298-303. PMID: 17827415.
      View in: PubMed
    61. Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF. MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl). 2007 Jan; 189(4):531-7. PMID: 17082969.
      View in: PubMed
    62. Levine AJ, Hinkin CH, Marion S, Keuning A, Castellon SA, Lam MM, Robinet M, Longshore D, Newton T, Myers H, Durvasula RS. Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol. 2006 May; 25(3):329-35. PMID: 16719604.
      View in: PubMed
    63. Newton TF, De La Garza R, Fong T, Chiang N, Holmes TH, Bloch DA, Anderson A, Elkashef A. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav. 2005 Dec; 82(4):704-11. PMID: 16413604.
      View in: PubMed
    64. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology. 2006 Jul; 31(7):1537-44. PMID: 16319910.
      View in: PubMed
    65. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl). 2005 Nov; 182(3):426-35. PMID: 16163531.
      View in: PubMed
    66. Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, Robinet M, Longshore D, Newton T, Myers H, Durvasula RS, Hardy DJ. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005 Sep; 9(3):355-62. PMID: 16088365.
      View in: PubMed
    67. Newton TF, Kalechstein AD, De La Garza R, Cutting DJ, Ling W. Apathy predicts hedonic but not craving response to cocaine. Pharmacol Biochem Behav. 2005 Sep; 82(1):236-40. PMID: 16181666.
      View in: PubMed
    68. Newton TF, De La Garza R, Kalechstein AD, Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav. 2005 Sep; 82(1):90-7. PMID: 16112720.
      View in: PubMed
    69. De La Garza R, Newton TF, Kalechstein AD. Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl). 2005 Mar; 178(2-3):347-50. PMID: 15452684.
      View in: PubMed
    70. Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict. 2004 May-Jun; 13(3):248-55. PMID: 15370944.
      View in: PubMed
    71. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004 Jan; 61(1):73-84. PMID: 14706946.
      View in: PubMed
    72. Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol. 2004 Jan; 115(1):194-8. PMID: 14706488.
      View in: PubMed
    73. Kalechstein AD, Newton TF, van Gorp WG. Neurocognitive functioning is associated with employment status: a quantitative review. J Clin Exp Neuropsychol. 2003 Dec; 25(8):1186-91. PMID: 14566590.
      View in: PubMed
    74. Houtsmuller EJ, Notes LD, Newton T, van Sluis N, Chiang N, Elkashef A, Bigelow GE. Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl). 2004 Feb; 172(1):31-40. PMID: 14605792.
      View in: PubMed
    75. Newton TF, Kalechstein AD, Tervo KE, Ling W. Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration. Addict Behav. 2003 Jun; 28(4):817-21. PMID: 12726795.
      View in: PubMed
    76. Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol. 2003 Mar; 114(3):410-5. PMID: 12705421.
      View in: PubMed
    77. Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci. 2003; 15(2):215-20. PMID: 12724464.
      View in: PubMed
    78. Kalechstein AD, Newton TF, Leavengood AH. Apathy syndrome in cocaine dependence. Psychiatry Res. 2002 Jan 31; 109(1):97-100. PMID: 11850056.
      View in: PubMed
    79. Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Res. 2001 Jul 24; 102(3):227-33. PMID: 11440773.
      View in: PubMed
    80. Hinkin CH, Castellon SA, Hardy DJ, Farinpour R, Newton T, Singer E. Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci. 2001; 13(2):248-54. PMID: 11449032.
      View in: PubMed
    81. Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci. 2000; 12(4):480-4. PMID: 11083165.
      View in: PubMed
    82. Uslaner J, Kalechstein A, Richter T, Ling W, Newton T. Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry. 1999 Sep; 156(9):1444-6. PMID: 10484960.
      View in: PubMed
    83. Bartzokis G, Beckson M, Newton T, Mandelkern M, Mintz J, Foster JA, Ling W, Bridge TP. Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology. 1999 Jun; 20(6):582-90. PMID: 10327427.
      View in: PubMed
    84. Gan X, Zhang L, Newton T, Chang SL, Ling W, Kermani V, Berger O, Graves MC, Fiala M. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. Clin Immunol Immunopathol. 1998 Nov; 89(2):181-90. PMID: 9787120.
      View in: PubMed
    85. Newton TF, Cook IA, Holschneider DP, Rosenblatt MR, Lindholm JE, Jarvik MM. Quantitative EEG effects of nicotine replacement by cigarette smoking. Neuropsychobiology. 1998; 37(2):112-6. PMID: 9566277.
      View in: PubMed
    86. Newton TF, Khalsa-Denison ME, Gawin FH. The face of craving? Facial muscle EMG and reported craving in abstinent and non-abstinent cocaine users. Psychiatry Res. 1997 Nov 14; 73(1-2):115-8. PMID: 9463845.
      View in: PubMed
    87. Newton TF, Leuchter AF, van Gorp WG, Hinkin CH, Mandelkern M, Weiner H. EEG power correlates with subcortical metabolic activity in AIDS. J Neuropsychiatry Clin Neurosci. 1997; 9(4):574-8. PMID: 9447499.
      View in: PubMed
    88. Fiala AM, Gan XH, Newton T, Chiappelli F, Shapshak P, Kermani V, Kung MA, Diagne A, Martinez O, Way D, Weinand M, Witte M, Graves M. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv Exp Med Biol. 1996; 402:145-56. PMID: 8787655.
      View in: PubMed
    89. Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry. 1994 Nov; 57(11):1347-54. PMID: 7964810; PMCID: PMC1073185.
    90. Newton TF, Leuchter AF, Walter DO, van Gorp WG, Morgenstern H, Miller EN, Lieb K, Visscher B, Satz P, Weiner H. Electroencephalographic coherence in acquired immune deficiency syndrome. Psychiatry Res. 1994 Oct; 54(1):1-11. PMID: 7701024.
      View in: PubMed
    91. Leuchter AF, Cook IA, Mena I, Dunkin JJ, Cummings JL, Newton TF, Migneco O, Lufkin RB, Walter DO, Lachenbruch PA. Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res. 1994 Sep; 55(3):141-52. PMID: 7870854.
      View in: PubMed
    92. Dunkin JJ, Leuchter AF, Newton TF, Cook IA. Reduced EEG coherence in dementia: state or trait marker? Biol Psychiatry. 1994 Jun 1; 35(11):870-9. PMID: 8054410.
      View in: PubMed
    93. Leuchter AF, Cook IA, Lufkin RB, Dunkin J, Newton TF, Cummings JL, Mackey JK, Walter DO. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage. 1994 Jun; 1(3):208-19. PMID: 9343572.
      View in: PubMed
    94. Newton TF, Leuchter AF, Miller EN, Weiner H. Quantitative EEG in patients with AIDS and asymptomatic HIV infection. Clin Electroencephalogr. 1994 Jan; 25(1):18-25. PMID: 8174287.
      View in: PubMed
    95. Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Rosenberg-Thompson S, Lachenbruch PA, Weiner H. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroencephalogr Clin Neurophysiol. 1993 Dec; 87(6):385-93. PMID: 7508371.
      View in: PubMed
    96. Newton TF, Leuchter AF, Walter DO, Van Gorp WC, Stern CE, Mandelkern M, Weiner H. EEG coherence in men with AIDS: association with subcortical metabolic activity. J Neuropsychiatry Clin Neurosci. 1993; 5(3):316-21. PMID: 8369642.
      View in: PubMed
    97. Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain. 1992 Oct; 115 ( Pt 5):1543-61. PMID: 1422803.
      View in: PubMed
    98. Reynolds CF, Shaw DH, Newton TF, Coble PA, Kupfer DJ. EEG sleep in outpatients with generalized anxiety: a preliminary comparison with depressed outpatients. Psychiatry Res. 1983 Feb; 8(2):81-9. PMID: 6574533.
      View in: PubMed
    99. Reynolds CF, Newton TF, Shaw DH, Coble PA, Kupfer DJ. Electroencephalographic sleep findings in depressed outpatients. Psychiatry Res. 1982 Feb; 6(1):65-75. PMID: 6949171.
      View in: PubMed
    NEWTON's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _